Top 10 ASX Dividend Stocks for Nov 2026 Download Free Report

Small Cap stocks

Dimerix Limited (ASX:DXB): Kidney Disease Trials and the Development of DMX-200

Dimerix Limited develops investigational medicines for diseases where treatment options remain limited, with a focus on kidney conditions. The company’s central development programme concerns DMX-200 and its ACTION3 Phase 3 trial in focal segmental glomerulosclerosis.

Aditi Sarkar | 30 October 2026

Paragon Care Limited (ASX:PGC): Healthcare Distribution and FY26 Operating Performance

Paragon Care Limited (ASX:PGC) is a healthcare wholesaler, distributor and manufacturer serving customers across the Asia Pacific region. The group’s FY26 performance reflected the interaction between healthcare distribution activity, business integration and the cost of supporting a broad product offering. Its investor centre reports …

Aditi Sarkar | 30 October 2026

Optiscan Imaging (ASX:OIL): Imaging Device Submissions and Clinical Studies

Optiscan Imaging Limited develops digital microscopy technology intended to provide real-time imaging of tissue. Two October US regulatory submissions and a series of research announcements form the principal company-specific developments available for this reporting date.

Aditi Sarkar | 30 October 2026

Lord Resources Limited (ASX:LRD): Lord Resources Focuses on Western Australian Lithium and Copper Exploration

Lord Resources (ASX:LRD) released quarterly activities and cash-flow reports during January, April and July 2026, followed by its 2026Annual Reportin September. These dated disclosures provide the relevant reporting periods for the company’s project holdings, exploration expenditure and available funding.

Sonal Goyal | 29 October 2026

Adisyn (ASX:AI1) Reports Graphene Deposited on a Full 200mm Wafer and A$14.4m

Adisyn develops graphene materials for semiconductor and advanced materials applications. The deposition took place at below 300 degrees Celsius. Independent testing, including Raman spectroscopy and transmission electron microscopy, with work involving the Hebrew University of Jerusalem, found graphene at all 12 locations sampled across …

Aditi Sarkar | 29 October 2026

Appen (ASX:APX) Reports Q3 FY26 Revenue of US$73.9m and Kept its Full-year

Underlying EBITDA before foreign exchange effects was US$10.3m for the quarter, US$9.3m higher than a year earlier, and US$15.7m year to date. Appen said these figures exclude restructuring and transaction costs. Gross margin was 43.3%, which the company said was 410 basis points higher …

Aditi Sarkar | 29 October 2026

Star Entertainment Group (ASX:SGR) Details Facing a A$260 Million AUSTRAC Civil Penalty

The proceedings concerned historical breaches of the Anti-Money Laundering and Counter-Terrorism Financing Act 2006 by two subsidiaries, The Star Pty Limited and The Star Entertainment Qld Limited. According to the announcement, The Star accepted the penalty. The release does not mention any appeal. The …

Aditi Sarkar | 29 October 2026

Saferoads Holdings (ASX:SRH) Reports A$2.93m of September Quarter Sales and Approval

General product sales, which exclude the rentals segment, were A$2.604 million, up A$236,000 on the prior quarter. The company called this growth an encouraging sign and attributed it to additional senior sales staff and sales capture resources. It also said continued growth depends on …

Aditi Sarkar | 29 October 2026

AVADA Group (ASX:AVD) Reports A$66.4m in Quarterly Cash Receipts as the Traffic

According to the report, receipts of A$66.423m compared with operating cash expenditure of A$66.877m, giving the A$454k net outflow. Receipts rose 38.0 per cent on the prior-year quarter and operating spending rose 31.6 per cent. The company said the net operating outflow improved by …

Aditi Sarkar | 29 October 2026

Accent Group (ASX:AX1) Directors Are Still Recommending Shareholders Reject Frasers Group's A$0.65

Frasers is bidding for all Accent shares that it and its associates do not already own, at A$0.65 per share, through an on-market bid. The committee, which comprises all directors except Frasers' nominee David Forsey, said that Frasers has stated the price will not …

Aditi Sarkar | 29 October 2026
Support

Hi! How can we help you today?

Loading…